Insider Selling: Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Sells $126,020.00 in Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III sold 2,000 shares of the stock in a transaction dated Thursday, December 26th. The shares were sold at an average price of $63.01, for a total value of $126,020.00. Following the completion of the sale, the chief executive officer now owns 42,497 shares of the company’s stock, valued at approximately $2,677,735.97. This trade represents a 4.49 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Kewaunee Scientific Stock Performance

Kewaunee Scientific stock opened at $63.81 on Monday. Kewaunee Scientific Co. has a 12-month low of $27.00 and a 12-month high of $66.15. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.53 and a quick ratio of 2.00. The company has a market capitalization of $183.26 million, a price-to-earnings ratio of 10.11 and a beta of 0.80. The firm’s fifty day moving average price is $42.62 and its 200 day moving average price is $43.31.

Institutional Trading of Kewaunee Scientific

A number of hedge funds and other institutional investors have recently modified their holdings of KEQU. Ritholtz Wealth Management purchased a new position in Kewaunee Scientific in the second quarter valued at about $413,000. Dimensional Fund Advisors LP boosted its stake in shares of Kewaunee Scientific by 3.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock valued at $8,378,000 after buying an additional 6,132 shares during the last quarter. Renaissance Technologies LLC grew its position in shares of Kewaunee Scientific by 13.4% during the second quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock worth $4,230,000 after buying an additional 10,580 shares in the last quarter. Heron Bay Capital Management bought a new stake in shares of Kewaunee Scientific in the second quarter worth $252,000. Finally, De Lisle Partners LLP raised its holdings in Kewaunee Scientific by 36.6% in the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after acquiring an additional 11,511 shares in the last quarter. 32.69% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Wednesday, December 18th.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.